Biosensors Market by Product (Wearable biosensors and Non- Wearable biosensors), Technology (Electrochemical Biosensors, Optical Biosensors, Piezoelectric Biosensors, Thermal Biosensors, and Nanomechanical Biosensors): Global Opportunity Analysis and Industry Forecast, 2019–2026
- ALL3931796
- 163 Pages
- May 2020
- Medical Devices
Significant rise in chronic diseases such as diabetes across the globe, surge in biotechnology R&D, and increased demand for home care devices are the major factors that drive the biosensors market growth. In addition, considerable increase in preference of biosensors in glucose monitoring devices contributes to the market growth. However, high cost associated with these devices and lack of inclination toward adoption of new treatment devices are the major factors anticipated to hamper the market growth. On the contrary, technological advancements in biosensors to make them portable and easy to handle is anticipated to create lucrative opportunities in the future.
The market is segmented on the basis of product, technology and region. Based on product, the global biosensors market is divided into wearable biosensors and nonwearable biosensors. Based on technology, the market is classified into electrochemical biosensors, optical biosensors, piezoelectric biosensors, thermal biosensors and nanomechanical biosensors. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Prominent players in the market have adopted various strategies such as product approval and partnership for maintaining their share in the global biosensors market, thereby addressing the evolving healthcare needs among patients and healthcare providers. Some of the key players of the market include Abbott Laboratories, AgaMatrix Holdings LLC, DowDupont Inc. (DuPont de Nemours, Inc.), F. Hoffmann-La Roche Ltd., General Electric (Biacore, Inc.), LifeScan, Inc., Medtronic Plc., Nova Biomedical, PHC Holdings Co., Ltd. (Ascensia Diabetes Care Holdings AG), and Siemens Healthcare.
KEY BENEFITS FOR STAKEHOLDERS
The study provides an in-depth analysis of the market along with the current trends and future estimations to elucidate the imminent investment pockets.
It offers a quantitative analysis from 2018 to 2026, which is expected to enable the stakeholders to capitalize on prevailing market opportunities.
Comprehensive analysis of all geographical regions is provided to determine the prevailing opportunities.
Key players are profiled, and their strategies are analyzed thoroughly to understand the competitive outlook of the global market.
KEY MARKET SEGMENTS
By Product
• Wearable Biosensors
• Non- Wearable Biosensors
By Technology
• Electrochemical Biosensors
• Optical Biosensors
• Piezoelectric Biosensors
• Thermal Biosensors
• Nanomechanical Biosensors
By Region
• North America
o U.S.
o Canada
o Mexico
• Europe
o Germany
o France
o UK
o Italy
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Rest of Asia-Pacific
• LAMEA
o Brazil
o Saudi Arabia
o South Africa
o Rest of LAMEA
LIST OF KEY PLAYERS PROFILED IN THE REPORT
• Abbott Laboratories
• AgaMatrix Holdings LLC
• DowDupont Inc
• F. Hoffmann-La Roche Ltd.
• General Electric
• LifeScan, Inc.
• Medtronic Plc
• Nova Biomedical
• PHC Holdings Co., Ltd
• Siemens Healthcare
1.1.Report description
1.2.Key benefits for stakeholders
1.3.Research methodology
1.3.1.Secondary research
1.3.2.Primary research
1.3.3.Analyst Tools and Models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO perspective
CHAPTER 3:MARKET OVERVIEW
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.3.Porter’s five forces analysis
3.3.1.Moderate bargaining power of buyers
3.3.2.Low bargaining power of suppliers
3.3.3.Moderate threat of substitutes
3.3.4.Low threat of new entrants
3.3.5.Moderate competitive rivalry
3.4.Top player positioning
3.5.Market Dynamics
3.5.1.Drivers
3.5.1.1.Rise in R&D investments
3.5.1.2.Development of nanotechnology-based biosensors
3.5.2.Restraint
3.5.2.1.High cost associated with R&D
3.5.3.Opportunity
3.5.3.1.Various growth opportunities in emerging economies
CHAPTER 4:BIOSENSORS MARKET, BY PRODUCT
4.1.Overview
4.1.1.Market size and forecast
4.2.Wearable biosensors
4.2.1.Key market trends and opportunities
4.2.2.Market size and forecast
4.2.3.Market share analysis, by country
4.3.Non wearable biosensors
4.3.1.Key market trends and opportunities
4.3.2.Market size and forecast
4.3.3.Market share analysis, by country
CHAPTER 5:BIOSENSORS MARKET, BY TECHNOLOGY
5.1.Overview
5.1.1.Market size and forecast
5.2.Electrochemical Biosensors
5.2.1.Market size and forecast
5.2.2.Market share analysis, by country
5.3.Optical Biosensors
5.3.1.Market size and forecast
5.3.2.Market share analysis, by country
5.4.Piezoelectric Biosensors
5.4.1.Market size and forecast
5.4.2.Market share analysis, by country
5.5.Thermal Biosensors
5.5.1.Market size and forecast
5.5.2.Market share analysis, by country
5.6.Nanomechanical Biosensors
5.6.1.Market size and forecast
5.6.2.Market share analysis, by country
CHAPTER 6:BIOSENSORS MARKET, BY REGION
6.1.Overview
6.1.1.Market size and forecast
6.2.North America
6.2.1.Key market trends and opportunities
6.2.2.Market size and forecast, by country
6.2.3.Market size and forecast, by technology
6.2.4.Market size and forecast, by product
6.2.5.U.S.
6.2.5.1.U.S. market size and forecast, by technology
6.2.5.2.U.S. market size and forecast, by product
6.2.6.Canada
6.2.6.1.Canada market size and forecast, by technology
6.2.6.2.Canada market size and forecast, by product
6.2.7.Mexico
6.2.7.1.Mexico market size and forecast, by technology
6.2.7.2.Mexico market size and forecast, by product
6.3.Europe
6.3.1.Key growth factors and opportunities
6.3.2.Market size and forecast, by country
6.3.3.Market size and forecast, by technology
6.3.4.Market size and forecast, by product
6.3.5.Germany
6.3.5.1.Germany market size and forecast, by technology
6.3.5.2.Germany market size and forecast, by product
6.3.6.France
6.3.6.1.France market size and forecast, by technology
6.3.6.2.France market size and forecast, by product
6.3.7.UK
6.3.7.1.UK market size and forecast, by technology
6.3.7.2.UK market size and forecast, by product
6.3.8.Italy
6.3.8.1.Italy market size and forecast, by technology
6.3.8.2.Italy market size and forecast, by product
6.3.9.Rest of Europe
6.3.9.1.Rest of Europe market size and forecast, by technology
6.3.9.2.Rest of Europe market size and forecast, by product
6.4.Asia-Pacific
6.4.1.Key growth factors and opportunities.
6.4.2.Market size and forecast, by country
6.4.3.Market size and forecast, by technology
6.4.4.Market size and forecast, by product
6.4.5.Japan
6.4.5.1.Japan market size and forecast, by technology
6.4.5.2.Japan market size and forecast, by product
6.4.6.China
6.4.6.1.China market size and forecast, by technology
6.4.6.2.China market size and forecast, by product
6.4.7.India
6.4.7.1.India market size and forecast, by technology
6.4.7.2.India market size and forecast, by product
6.4.8.Rest of Asia-Pacific
6.4.8.1.Rest of Asia-Pacific market size and forecast, by technology
6.4.8.2.Rest of Asia-Pacific market size and forecast, by product
6.5.LAMEA
6.5.1.Key growth factors and opportunities
6.5.2.Market size and forecast, by country
6.5.3.Market size and forecast, by technology
6.5.4.Market size and forecast, by product
6.5.5.Brazil
6.5.5.1.Brazil market size and forecast, by technology
6.5.5.2.Brazil market size and forecast, by product
6.5.6.Saudi Arabia
6.5.6.1.Saudi Arabia market size and forecast, by technology
6.5.6.2.Saudi Arabia market size and forecast, by product
6.5.7.South Africa
6.5.7.1.South Africa market size and forecast, by technology
6.5.7.2.South Africa market size and forecast, by product
6.5.8.Rest of LAMEA
6.5.8.1.Rest of LAMEA market size and forecast, by technology
6.5.8.2.Rest of LAMEA market size and forecast, by product
CHAPTER 7:COMPANY PROFILES
7.1.ABBOTT LABORATORIES
7.1.1.Company overview
7.1.2.Company snapshot
7.1.3.Operating business segments
7.1.4.Product portfolio
7.1.5.Business performance
7.1.6.Key strategic moves and developments
7.2.AGAMATRIX HOLDINGS LLC
7.2.1.Company overview
7.2.2.Company snapshot
7.2.3.Operating business segments
7.2.4.Product portfolio
7.2.5.Business performance
7.2.1.Key strategic moves and developments
7.3.DOWDUPONT INC. (DUPONT DE NEMOURS, INC.)
7.3.1.Company overview
7.3.2.Company snapshot
7.3.3.Operating business segments
7.3.4.Product Portfolio
7.3.5.Business performance
7.4.F. HOFFMANN-LA ROCHE LTD.
7.4.1.Company overview
7.4.2.Company snapshot
7.4.3.Operating business segments
7.4.4.Product portfolio
7.4.5.Business performance
7.4.6.Key strategic moves and developments
7.5.GENERAL ELECTRIC (BIACORE, INC.)
7.5.1.Company overview
7.5.2.Company snapshot
7.5.3.Operating business segments
7.5.4.Product portfolio
7.5.5.Business performance
7.6.LIFESCAN, INC.
7.6.1.Company overview
7.6.2.Company snapshot
7.6.3.Operating business segments
7.6.4.Product portfolio
7.6.5.Business performance
7.7.MEDTRONIC PLC.
7.7.1.Company overview
7.7.2.Company snapshot
7.7.3.Operating business segments
7.7.4.Product portfolio
7.7.5.Business performance
7.8.NOVA BIOMEDICAL
7.8.1.Company overview
7.8.2.Company snapshot
7.8.3.Operating business segments
7.8.4.Product portfolio
7.8.5.Business performance
7.8.6.Key strategic moves and developments
7.9.PHC HOLDINGS CO., LTD. (ASCENSIA DIABETES CARE HOLDINGS AG)
7.9.1.Company overview
7.9.2.Company snapshot
7.9.3.Operating business segments
7.9.4.Product portfolio
7.9.5.Business performance
7.10.SIEMENS
7.10.1.Company overview
7.10.2.Company snapshot
7.10.3.Operating business segments
7.10.4.Product portfolio
7.10.5.Business performance
TABLE 01.BIOSENSORS MARKET, BY PRODUCT, 2018–2026 ($MILLION)
TABLE 02.BIOSENSORS MARKET FOR WEARABLE BIOSENSORS, BY REGION, 2018–2026 ($MILLION)
TABLE 03.BIOSENSORS CORTICOSTEROIDS MARKET FOR NON-WEARABLE BIOSENSORS, BY REGION, 2018–2026 ($MILLION)
TABLE 04.BIOSENSORS MARKET, BY TECHNOLOGY, 2018–2026 ($MILLION)
TABLE 05.BIOSENSORS MARKET FOR ELECTROCHEMICAL BIOSENSORS MARKET, BY REGION, 2018–2026 ($MILLION)
TABLE 06.BIOSENSORS MARKET FOR OPTICAL BIOSENSORS, BY REGION, 2018–2026 ($MILLION)
TABLE 07.BIOSENSORS MARKET FOR PIEZOELECTRIC BIOSENSORS, BY REGION, 2018–2026 ($MILLION)
TABLE 08.BIOSENSORS MARKET FOR THERMAL BIOSENSORS, BY REGION, 2018–2026 ($MILLION)
TABLE 09.BIOSENSORS MARKET FOR NANOMECHANICAL BIOSENSORS, BY REGION, 2018–2026 ($MILLION)
TABLE 10.BIOSENSORS MARKET, BY REGION, 2018–2026 ($MILLION)
TABLE 11.NORTH AMERICA BIOSENSORS MARKET, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 12.NORTH AMERICA BIOSENSORS MARKET, BY TECHNOLOGY, 2018–2026 ($MILLION)
TABLE 13.NORTH AMERICA BIOSENSORS MARKET, BY PRODUCT, 2018–2026 ($MILLION),
TABLE 14.U.S. BIOSENSORS MARKET, BY TECHNOLOGY, 2018–2026 ($MILLION)
TABLE 15.U.S. BIOSENSORS MARKET BY PRODUCT, 2018–2026 ($MILLION)
TABLE 16.CANADA BIOSENSORS MARKET, BY TECHNOLOGY, 2018–2026 ($MILLION)
TABLE 17.CANADA BIOSENSORS MARKET BY PRODUCT, 2018–2026 ($MILLION)
TABLE 18.MEXICO BIOSENSORS MARKET, BY TECHNOLOGY, 2018–2026 ($MILLION)
TABLE 19.MEXICO BIOSENSORS MARKET BY PRODUCT, 2018–2026 ($MILLION)
TABLE 20.EUROPE BIOSENSORS MARKET, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 21.EUROPE BIOSENSORS MARKET, BY TECHNOLOGY, 2018–2026 ($MILLION)
TABLE 22.EUROPE BIOSENSORS MARKET, BY PRODUCT, 2018–2026 ($MILLION),
TABLE 23.GERMANY BIOSENSORS MARKET BY TECHNOLOGY, 2018–2026 ($MILLION)
TABLE 24.GERMANY BIOSENSORS MARKET BY PRODUCT, 2018–2026 ($MILLION)
TABLE 25.FRANCE BIOSENSORS MARKET, BY TECHNOLOGY, 2018–2026 ($MILLION)
TABLE 26.FRANCE BIOSENSORS MARKET BY PRODUCT, 2018–2026 ($MILLION)
TABLE 27.UK BIOSENSORS MARKET, BY TECHNOLOGY, 2018–2026 ($MILLION)
TABLE 28.UK BIOSENSORS MARKET BY PRODUCT, 2018–2026 ($MILLION)
TABLE 29.ITALY BIOSENSORS MARKET, BY TECHNOLOGY, 2018–2026 ($MILLION)
TABLE 30.ITALY BIOSENSORS MARKET BY PRODUCT, 2018–2026 ($MILLION)
TABLE 31.REST OF EUROPE BIOSENSORS MARKET, BY TECHNOLOGY, 2018–2026 ($MILLION)
TABLE 32.REST OF EUROPE BIOSENSORS MARKET BY PRODUCT, 2018–2026 ($MILLION)
TABLE 33.ASIA-PACIFIC BIOSENSORS MARKET, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 34.ASIA-PACIFIC BIOSENSORS MARKET, BY TECHNOLOGY, 2018–2026 ($MILLION)
TABLE 35.ASIA-PACIFIC BIOSENSORS MARKET, BY PRODUCT, 2018–2026 ($MILLION),
TABLE 36.JAPAN BIOSENSORS MARKET, BY TECHNOLOGY, 2018–2026 ($MILLION)
TABLE 37.JAPAN BIOSENSORS MARKET BY PRODUCT, 2018–2026 ($MILLION)
TABLE 38.CHINA BIOSENSORS MARKET, BY TECHNOLOGY, 2018–2026 ($MILLION)
TABLE 39.CHINA BIOSENSORS MARKET BY PRODUCT, 2018–2026 ($MILLION)
TABLE 40.INDIA BIOSENSORS MARKET, BY TECHNOLOGY, 2018–2026 ($MILLION)
TABLE 41.INDIA BIOSENSORS MARKET BY PRODUCT, 2018–2026 ($MILLION)
TABLE 42.REST OF ASIA- PACIFIC BIOSENSORS MARKET, BY TECHNOLOGY, 2018–2026 ($MILLION)
TABLE 43.REST OF ASIA- PACIFIC BIOSENSORS MARKET BY PRODUCT, 2018–2026 ($MILLION)
TABLE 44.LAMEA BIOSENSORS MARKET, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 45.LAMEA BIOSENSORS MARKET, BY TECHNOLOGY, 2018–2026 ($MILLION)
TABLE 46.LAMEA BIOSENSORS MARKET, BY PRODUCT, 2018–2026 ($MILLION),
TABLE 47.BRAZIL BIOSENSORS MARKET, BY TECHNOLOGY, 2018–2026 ($MILLION)
TABLE 48.BRAZIL BIOSENSORS MARKET BY PRODUCT, 2018–2026 ($MILLION)
TABLE 49.SAUDI ARABIA BIOSENSORS MARKET, BY TECHNOLOGY, 2018–2026 ($MILLION)
TABLE 50.SAUDI ARABIA BIOSENSORS MARKET BY PRODUCT, 2018–2026 ($MILLION)
TABLE 51.SOUTH AFRICA BIOSENSORS MARKET, BY TECHNOLOGY, 2018–2026 ($MILLION)
TABLE 52.SOUTH AFRICA BIOSENSORS MARKET BY PRODUCT, 2018–2026 ($MILLION)
TABLE 53.REST OF LAMEA BIOSENSORS MARKET, BY TECHNOLOGY, 2018–2026 ($MILLION)
TABLE 54.REST OF LAMEA BIOSENSORS MARKET BY PRODUCT, 2018–2026 ($MILLION)
TABLE 55.ABBOTT: COMPANY SNAPSHOT
TABLE 56.ABBOTT: OPERATING SEGMENTS
TABLE 57.ABBOTT: PRODUCT PORTFOLIO
TABLE 58.AGAMATRIX: COMPANY SNAPSHOT
TABLE 59.AGAMATRIX: PRODUCT PORTFOLIO
TABLE 60.DUPONT: COMPANY SNAPSHOT
TABLE 61.DUPONT: OPERATING SEGMENTS
TABLE 62.DUPONT: PRODUCT PORTFOLIO
TABLE 63.ROCHE: COMPANY SNAPSHOT
TABLE 64.ROCHE: OPERATING SEGMENTS
TABLE 65.ROCHE: PRODUCT PORTFOLIO
TABLE 66.GE HEALTHCARE: COMPANY SNAPSHOT
TABLE 67.GE HEALTHCARE: PRODUCT SEGMENTS
TABLE 68.GE HEALTHCARE: PRODUCT PORTFOLIO
TABLE 69.LIFESCAN: COMPANY SNAPSHOT
TABLE 70.LIFESCAN: PRODUCT PORTFOLIO
TABLE 71.MEDTRONIC: COMPANY SNAPSHOT
TABLE 72.MEDTRONIC: OPERATING SEGMENTS
TABLE 73.MEDTRONIC: PRODUCT PORTFOLIO
TABLE 74.NOVA: COMPANY SNAPSHOT
TABLE 75.NOVA: PRODUCT PORTFOLIO
TABLE 76.PHC: COMPANY SNAPSHOT
TABLE 77.PHC: OPERATING SEGMENTS
TABLE 78.PHC: PRODUCT PORTFOLIO
TABLE 79.SIEMENS: COMPANY SNAPSHOT
TABLE 80.SIEMENS: OPERATING SEGMENTS
TABLE 81.SIEMENS: PRODUCT PORTFOLIO
Similar Reports
Medical implants are permanent devices such as pacemakers or temporary devices such as fracture plates which are removed once their function is completed. These implants are made up of bone, tissue, skin, ceramics, metals, plastics, and other natural materials...
- Publish Date: August 21, 2016
- $5370
Ostomy is a surgery wherein an artificial opening, known as stoma, is created from the colon in the human body to eliminate body wastes such as urine, mucus, and stools, which are collected in artificial bags called ostomy drainage bags. These plastic/rub...
- Publish Date: December 1, 2016
- $5370
Laparoscopy is a minimally invasive procedure used to examine organs inside the abdomen or pelvic cavities by inserting a laparoscope through a small incision in the abdomen. A laparoscope comprises a long, thin tube with high-intensity light, and high-re...
- Publish Date: April 24, 2017
- $5370
